To explore whether ROS induction mediated by trametinib plus CuET is essential for the upregulation of JUN in BRAF WT melanoma cells, we analyzed JUN expression following treatment with the combination in the presence of the ROS scavenger NAC (Supplementary Fig. 4E). Here, JUN is linked to melanoma.